Not applicableStudy completedNCT00211042
What this trial is testing
Patients With Pure Red Cell Aplasia Associated With Recombinant Human Erythropoietin Treatment
Who this might be right for
Pure Red-cell Aplasia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 52